Advanced search
Publication Cover
International Journal of General Medicine Volume 14, 2021 - Issue
Submit an article Journal homepage
115
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Changes in Bone Mineral Density Following Conventional Oral Phosphonate Treatment of Hypophosphatemic Osteomalacia: A Non-Randomized Controlled Study

Yue Guo1 National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People’s Republic of China;2 Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, People’s Republic of ChinaView further author information
,
Ying-Hui Zhou1 National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People’s Republic of ChinaView further author information
,
Xian-Ping Wu1 National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People’s Republic of ChinaView further author information
,
Chen-Yi Tang1 National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1780-7997View further author information
ORCID Icon,
Min Wang3 Department of Endocrinology, Xiangya Hospital of Central South University, Changsha, 410008, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2111-3074View further author information
ORCID Icon,
Zhao-Hui Mo4 Department of Endocrinology, The Third Xiangya Hospital of Central South University, Changsha, 410013, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-3994-4055View further author information
ORCID Icon,
John A Shepherd5 Department of Radiology & Biomedical Imaging, University of California at San Francisco, San Francisco, CA, 94143, USAORCID Iconhttps://orcid.org/0000-0003-2280-2541View further author information
ORCID Icon,
Bennett K Ng5 Department of Radiology & Biomedical Imaging, University of California at San Francisco, San Francisco, CA, 94143, USAView further author information
,
Bo Fan5 Department of Radiology & Biomedical Imaging, University of California at San Francisco, San Francisco, CA, 94143, USAView further author information
&
Hou-De Zhou1 National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 7925-7931 | Published online: 08 Nov 2021

References

  • Kinoshita Y, Fukumoto S. X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases: prospect for new treatment. Endocr Rev. 2018;39(3):274–291. doi:10.1210/er.2017-00220
  • Bockenhauer D, Bokenkamp A, Van’t Hoff W, et al. Renal phenotype in Lowe syndrome: a selective proximal tubular dysfunction. Clin J Am Soc Nephrol. 2008;3(5):1430–1436. doi:10.2215/CJN.00520108
  • Bergwitz C, Roslin NM, Tieder M, et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet. 2006;78(2):179–192. doi:10.1086/499409
  • Shanbhogue VV, Hansen S, Jorgensen NR, Beck-Nielsen SS. Impact of conventional medical therapy on bone mineral density and bone turnover in adult patients with X-linked hypophosphatemia: a 6-year prospective cohort study. Calcif Tissue Int. 2018;102(3):321–328. doi:10.1007/s00223-017-0363-3
  • Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna K. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 1992;75(3):879–885.
  • Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26(7):1381–1388. doi:10.1002/jbmr.340
  • Bhambri R, Naik V, Malhotra N, et al. Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom. 2006;9(1):120–127. doi:10.1016/j.jocd.2005.11.001
  • Jeong HJ, Lee JM, Lee TH, et al. Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis B and literature review. J Bone Metab. 2014;21(1):76–83. doi:10.11005/jbm.2014.21.1.76
  • Saghafi M, Azarian A, Hashemzadeh K, Sahebari M, Rezaieyazdi Z. Bone densitometry in patients with osteomalacia: is it valuable? Clin Cases Miner Bone Metab. 2013;10(3):180–182.
  • Arthur S, Chopra A. Familial hypophosphatemia: an unusual presentation with low back ache, heel pain, and a limp in a young man, and literature review. Clin Rheumatol. 2011;30(4):585–589. doi:10.1007/s10067-010-1607-z
  • Negri AL, Bogado CE, Zanchetta JR. Bone densitometry in a patient with hypophosphatemic osteomalacia. J Bone Miner Metab. 2004;22(5):514–517. doi:10.1007/s00774-004-0516-0
  • El-Desouki MI, Othman SM, Fouda MA. Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J. 2004;25(3):355–358.
  • El-Desouki M, Al-Jurayyan N. Bone mineral density and bone scintigraphy in children and adolescents with osteomalacia. Eur J Nucl Med. 1997;24(2):202–205. doi:10.1007/BF02439554
  • Cosman F, Schnitzer MB, McCann PD, Parisien MV, Dempster DW, Lindsay R. Relationships between quantitative histological measurements and noninvasive assessments of bone mass. Bone. 1992;13(3):237–242. doi:10.1016/8756-3282(92)90203-9
  • Fukumoto S. The role of bone in phosphate metabolism. Mol Cell Endocrinol. 2009;310(1–2):63–70. doi:10.1016/j.mce.2008.08.031
  • Martin A, David V, Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev. 2012;92(1):131–155. doi:10.1152/physrev.00002.2011
  • Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Invest. 1985;75(6):1858–1868. doi:10.1172/JCI111900
  • Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab. 2010;95(4):1846–1850. doi:10.1210/jc.2009-1671
  • Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393–4408. doi:10.1172/JCI46122

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.